Confidential Treatment Requested Centrexion Therapeutics Corporation PATENT ASSIGNMENT AND LICENSING AGREEMENT dated NOVEMBER 11, 2015 by and between BOEHRINGER INGELHEIM INTERNATIONAL GMBH hereinafter “BII” and CENTREXION THERAPEUTICS CORPORATION...Patent Assignment and Licensing Agreement • November 5th, 2018 • Centrexion Therapeutics Corp • Pharmaceutical preparations
Boehringer Ingelheim International GmbH (“BII”), a German limited liability company, with offices at Binger Straße 173, 55216 Ingelheim am Rhein, Germany; and
PATENT ASSIGNMENT AND LICENSING AGREEMENTPatent Assignment and Licensing Agreement • April 4th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations • New York
This Patent Assignment and Licensing Agreement (“Agreement”) is entered into on the date of last signature hereto (“Effective Date”)
Confidential Treatment Requested Centrexion Therapeutics Corporation AMENDMENT #1 TO PATENT ASSIGNMENT AND LICENSING AGREEMENTPatent Assignment and Licensing Agreement • November 9th, 2018 • Centrexion Therapeutics Corp • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) to the Patent Assignment and Licensing Agreement by and between Boehringer Ingelheim International GmbH (“BII”) and Centrexion Therapeutics Corporation (“CENTREXION”), dated November 11, 2015, (the “Agreement”) is entered into effective as of January 29, 2018.
SIDE LETTER RELATING TO PATENT ASSIGNMENT AND LICENSING AGREEMENT (“Side Letter”)Patent Assignment and Licensing Agreement • May 11th, 2023 • Vascular Biogenics Ltd. • Pharmaceutical preparations
This Side Letter, effective as of its date of last signature, relates to the Patent Assignment and Licensing Agreement by and between Boehringer Ingelheim International GmbH (“BII”) and Oncoheroes Biosciences Inc. (“Oncoheroes”), dated August 1, 2019, as amended by Amendment nr. 1 effective on April 5, 2020 (the “Agreement”).
Confidential Treatment Requested Centrexion Therapeutics Corporation AMENDMENT #1 TO PATENT ASSIGNMENT AND LICENSING AGREEMENTPatent Assignment and Licensing Agreement • November 5th, 2018 • Centrexion Therapeutics Corp • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) to the Patent Assignment and Licensing Agreement by and between Boehringer Ingelheim International GmbH (“BII”) and Centrexion Therapeutics Corporation (“CENTREXION”), dated November 11, 2015, (the “Agreement”) is entered into effective as of January 29, 2018.
Confidential Treatment Requested Centrexion Therapeutics Corporation AMENDMENT #1 TO PATENT ASSIGNMENT AND LICENSING AGREEMENTPatent Assignment and Licensing Agreement • October 19th, 2018 • Centrexion Therapeutics Corp • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) to the Patent Assignment and Licensing Agreement by and between Boehringer Ingelheim International GmbH (“BII”) and Centrexion Therapeutics Corporation (“CENTREXION”), dated November 11, 2015, (the “Agreement”) is entered into effective as of January 29, 2018.
